Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Instituto D’Or de Pesquisa e Ensino (IDOR) is a premier Brazilian non-profit organization dedicated to advancing scientific research, innovation, and education within the healthcare sector. Established in 2010 and supported by Rede D’Or São Luiz, the institute operates as a sophisticated hub for clinical trials and basic science, particularly in the fields of neuroscience, oncology, and intensive care. IDOR is internationally recognized for its pioneering use of induced pluripotent stem cells (iPSCs) to model complex neurological diseases and screen potential therapeutic compounds. The institute maintains extensive collaborations with global academic institutions and pharmaceutical companies to bridge the gap between laboratory discoveries and clinical applications. With a robust infrastructure across multiple Brazilian states, IDOR plays a critical role in training the next generation of medical researchers while driving high-impact scientific publications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Instituto D’Or de Pesquisa e Ensino.